This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: The University of Chicago, Arch Development Corporation, Ur Labs, Inc.. Active years: 1999-2019.
Company Filing History:
4 out of 962 
1 out of 349 
1 out of 2 Years Active: 1999-2019
Title: Innovations of Chun-Su Yuan
Introduction
Chun-Su Yuan is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of medicine, particularly in the development of opioid receptor antagonists. With a total of 8 patents, his work focuses on addressing the challenges associated with opioid use and its side effects.
Latest Patents
Chun-Su Yuan's latest patents include innovative methods and particles that contain an opioid receptor antagonist. These particles are designed to treat and prevent opioid-induced side effects in patients, particularly benefiting chronic opioid users. Another notable invention involves the use of opioid antagonists to attenuate endothelial cell proliferation and migration. This invention provides methods to inhibit or reduce cellular proliferation and migration, especially in relation to angiogenesis, using peripherally restricted opioid antagonists.
Career Highlights
Throughout his career, Chun-Su Yuan has worked with esteemed institutions, including the University of Chicago. His research has significantly advanced the understanding and treatment of opioid-related issues, showcasing his dedication to improving patient outcomes.
Collaborations
Chun-Su Yuan has collaborated with notable colleagues, including Jonathan Moss and Joseph F Foss. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Chun-Su Yuan's work exemplifies the impact of innovation in the medical field, particularly in addressing the complexities of opioid use. His patents and research continue to pave the way for advancements in treatment options for patients.